Pharmaceutical Investing La Jolla Pharmaceutical Company Announces U.S. FDA’s Grant of Breakthrough Therapy Designation for LJPC-0118
Pharmaceutical Investing Sage Announces Pivotal Phase 3 Trial Status for SAGE-217 in Major Depressive Disorder and Postpartum Depression based on FDA Breakthrough Therapy Meetin
Grande Portage Stakes Added Claims to Accommodate Potential Surface Facilities at the New Amalga Gold Project
Blue Lagoon Resources to Showcase Dome Mountain Gold Project at 121 Mining Investment Conference in London
American Salars Starts Sampling at 100% Owned Brazilian LCT Pegmatite Project, with Past Samples Hitting 3.72% Li2o and Significant Ree Values
